Inhibition of HMGB1 expression promoted the nuclear translocation of nuclear factor erythroid 2-related factor 2 (NRF2) and enhanced HO-1 levels, thereby reducing NLRP3 expression and partially reversing lung fibrosis (Huang et al., 2023). The gene discussed is HMGB1; the disease is pulmonary fibrosis.